healthcare
healthcare Articles
While Americans have access to vaccinations against a large number of diseases, they should ask their doctor about these six in particular.
Published:
Last Updated:
The analysts at SunTrust Robinson Humphrey put together a big list stocks ideas that they feel will outperform into year-end 2019. That list includes these five health care stocks with sizable upside.
Published:
Last Updated:
Now, Mereo BioPharma is taking steps towards a solution to ovarian cancer with its most recent update from the FDA.
Published:
Last Updated:
DBV Technologies shares dipped on Monday after the firm announced an update from the FDA. Although it was a positive update for the company, this appears to be a case of “sell the news.”
Published:
Last Updated:
Sarepta shares jumped on Friday after the firm announced an update from its Duchenne muscular dystrophy trial.
Published:
Last Updated:
The FDA is coming down hard after the disclosure that Zantac and other generic ranitidine drugs could contain impurities and carcinogens.
Published:
Last Updated:
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
Published:
Last Updated:
Canopy Growth shares dipped on Wednesday following the markets lower after the firm announced that it will purchase a majority stake in a leading producer of sports nutrition products.
Published:
Last Updated:
On days when the main stock market indexes are trading sharply lower, it is interesting to see what stocks and sectors are up on the day.
Published:
Last Updated:
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
Published:
Last Updated:
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Published:
Last Updated:
Conformis shares shot up on Tuesday after the firm announced that it has entered into definitive agreements to sell and license to Stryker to develop, manufacture and supply PSI for use in connection...
Published:
Last Updated:
Minerva Neurosciences shares dropped sharply on Tuesday after the firm announced that it was the victim of a cyberattack. Minerva also provided an update on its clinical trials.
Published:
Last Updated:
Catabasis Pharma shares jumped early on Tuesday after the firm announced that it had completed the enrollment for its late-stage Duchenne muscular dystrophy (DMD) study. Specifically, the enrollment...
Published:
Last Updated:
Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in...
Published:
Last Updated: